Provided by Tiger Trade Technology Pte. Ltd.

Sequoia Capital Holdings

3,413.42
+37.041.10%
Number of Gainers:65
Number of Losers:32
Number of Flat:3
PE:- -
High:3,429.07
Open:3,376.52
Low:3,376.52
Close:3,376.42
Volume:888.24M
Turnover:189.30B
Market Cap:44.85T
Float Cap:41.92T

Loading ...

Microsoft Corp. Stock Advances 3.7%, Outperforms Peers

Dow Jones
·
Sep 26

OpenAI Works to Understand Full Scope of Agent Activity as User Data Leak Emerges

Reuters
·
Sep 26

Brookfield Infrastructure Partners L.P. Stock Rises Friday, Outperforms Market

Dow Jones
·
Sep 26

Merck & Co - Daiichi Sankyo and Merck Withdraw Bla for Ifinatamab Deruxtecan in Es-Sclc in U.S.

THOMSON REUTERS
·
Sep 26

Merck & Co - Withdrawal Based on FDA Discussions; Phase 2 Data Do not Satisfy Approval Requirements

THOMSON REUTERS
·
Sep 26

Merck & Co - Patient Enrollment Continues in Ideate-Lung02 Phase 3 Trial for Ifinatamab Deruxtecan

THOMSON REUTERS
·
Sep 26

Merck & Co - Two Additional Phase 3 Trials Underway for Ifinatamab Deruxtecan in Crpc and Escc

THOMSON REUTERS
·
Sep 26

US Equity Indexes Rose This Week as Mega-Cap Tech Jumps While Iran Proposes Conditional Reopening of Hormuz Chokepoint

MT Newswires Live
·
Sep 26

Stock Market Today: SPY, QQQ Rallied after Trump-Xi Summit Concluded; Oil Slipped 2%

TIPRANKS
·
Sep 26

Intel Corp Stock (INTC) Closed Down by 3.45% on Sep 25: A Full Analysis

TradingKey
·
Sep 26

Nordhealth Insider Boosts Stake in Cloud Healthcare SaaS Provider

TIPRANKS
·
Sep 26

Dow's 500-Point Rally Highlighted by Gains in Shares of Microsoft, Sherwin-Williams Co.

Dow Jones
·
Sep 26

Google’s PageBreak finds over 500 XSS flaws in its web apps

cryptonews
·
Sep 26

Sector Update: Healthcare

MT Newswires Live
·
Sep 26

Costco Wholesale's Growth Story Is Evolving, Not Ending, UBS Says

MT Newswires Live
·
Sep 26

General Dynamics Director Robert K. Steel Disposes of Common Shares Worth $1.86 Million

Reuters
·
Sep 26

FDA approves Incyte’s Atebrioz for fibrodysplasia ossificans progressiva

TIPRANKS
·
Sep 26

US FDA Approves Mirum's Drug for Rare Bone Disorder

Reuters
·
Sep 26

FDA: Approves Atebrioz (Zilurgisertib) for Fibrodysplasia Ossificans Progressiva in Adults & Pediatric Patients 12 Years + - Website

THOMSON REUTERS
·
Sep 26

FDA : Atebrioz Recommended Dosage 100 Mg Once Daily

THOMSON REUTERS
·
Sep 26